Published in Liver Int on September 24, 2013
Perioperative Non-Invasive Indocyanine Green-Clearance Testing to Predict Postoperative Outcome after Liver Resection. PLoS One (2016) 0.77
Prognostic Impact of Indocyanine Green Plasma Disappearance Rate in Hepatocellular Carcinoma Patients after Radiofrequency Ablation: A Prognostic Nomogram Study. Intern Med (2017) 0.75
Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol (2006) 5.17
Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol (2004) 2.81
Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04
The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: a randomized study. World J Gastroenterol (2006) 1.78
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96. J Clin Oncol (2008) 1.65
Cytogenetic risk stratification in chronic myelomonocytic leukemia. Haematologica (2010) 1.60
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial. Transplantation (2016) 1.59
Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis. Blood (2003) 1.49
Exfoliative rejection after intestinal transplantation in children. Pediatr Transplant (2003) 1.48
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group. Haematologica (2010) 1.44
Clinically relevant differences in the model for end-stage liver disease and model for end-stage liver disease-sodium scores determined at three university-based laboratories of the same area. Liver Transpl (2009) 1.43
Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy. J Clin Oncol (2010) 1.22
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens. Blood (2010) 1.20
All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia. Blood (2004) 1.14
Peripheral nerve stimulation for the treatment of occipital neuralgia and transformed migraine using a c1-2-3 subcutaneous paddle style electrode: a technical report. Neuromodulation (2004) 1.09
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma. BMC Cancer (2010) 1.06
Right-sided diaphragmatic rupture after blunt trauma. An unusual entity. World J Emerg Surg (2011) 1.05
Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III. BMJ Open (2012) 1.04
Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg (2001) 0.98
Motor recovery and axonal plasticity with short-term amphetamine after stroke. Stroke (2008) 0.96
Patient outcomes in two steroid-free regimens using tacrolimus monotherapy after daclizumab induction and tacrolimus with mycophenolate mofetil in liver transplantation. Transplantation (2008) 0.96
Hepatic resection for liver metastases as part of the "oncosurgical" treatment of metastatic breast cancer. Ann Surg Oncol (2008) 0.95
Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation (2007) 0.91
Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol (2005) 0.90
A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C. Transpl Int (2005) 0.89
Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy. Haematologica (2004) 0.89
Single HCC in cirrhotic patients: liver resection or liver transplantation? Long-term outcome according to an intention-to-treat basis. Ann Surg Oncol (2012) 0.88
Outcome of patients following hepatic resection for metastatic cutaneous and ocular melanoma. J Hepatobiliary Pancreat Sci (2011) 0.87
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood (2006) 0.87
Full face transplant: the first case report. Ann Surg (2011) 0.86
Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre. Hepatol Int (2010) 0.86
Immunosuppression based on mycophenolate mofetil in stable liver transplanted patients. Int Immunopharmacol (2006) 0.85
Liver transplantation in infants weighing under 7 kilograms: management and outcome of PICU. Pediatr Transplant (2004) 0.84
Optimization of liver transplantation as a treatment of intrahepatic hepatocellular carcinoma recurrence after partial liver resection: experience of a single European series. World J Surg (2010) 0.84
Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital. Eur J Pediatr (2011) 0.83
Iron speciation study in Hfe knockout mice tissues: magnetic and ultrastructural characterisation. Biochim Biophys Acta (2009) 0.83
Our experience in liver transplantation in patients over 65 yr of age. Clin Transplant (2008) 0.83
Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function? Liver Transpl (2003) 0.83
FK506 in the maturation of dendritic cells. Haematologica (2002) 0.82
Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther (2006) 0.81
Transjugular intrahepatic portosystemic shunt for the treatment of sinusoidal obstruction syndrome in a liver transplant recipient and review of the literature. Liver Transpl (2012) 0.81
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease. Eur J Haematol (2013) 0.80
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia. Cancer (2011) 0.79
Visceral leishmaniasis among liver transplant recipients: an overview. Liver Transpl (2008) 0.79
Successful conversion from twice-daily to once-daily tacrolimus in liver transplantation: observational multicenter study. Clin Transplant (2011) 0.79
Liver biopsy-related infection in liver transplant recipients: A current matter of concern? Liver Transpl (2014) 0.78
Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia. Haematologica (2003) 0.78
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol. Haematologica (2004) 0.78
Rapamycin-based rescue therapy after chronic rejection in a pediatric liver transplant patient. Transpl Int (2003) 0.78
Ionic liquid mixtures--an analysis of their mutual miscibility. J Phys Chem B (2014) 0.78
Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation. Liver Transpl (2011) 0.77
Twelve-week posttreatment follow-up to predict sustained virologic response for recurrent hepatitis C infection in liver recipients. Transplantation (2012) 0.76
Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience. Am J Hematol (2012) 0.76
Treatment with mycophenolate mofetil followed by recombinant human erythropoietin in patients with low-risk myelodysplastic syndromes resistant to erythropoietin treatment. Haematologica (2010) 0.76
Does pre-liver transplant HBV DNA level affect HBV recurrence or survival in liver transplant recipients receiving HBIg and nucleos(t)ide analogues? Ann Hepatol (2011) 0.75
Xanthine oxidoreductase and preservation injury in human liver transplantation. Transplantation (2004) 0.75
Mycoplasma hominis infection after liver transplantation in a child. Transplantation (2004) 0.75
COSMO-RS analysis on mixing properties obtained for the systems 1-butyl-X-methylpyridinium tetrafluoroborate [X = 2,3,4] and 1,ω-dibromoalkanes [ω = 1-6]. Phys Chem Chem Phys (2011) 0.75
[Prevalence and prognostic significance of myeloid markers in adults with high-risk acute lymphoblastic leukemia]. Med Clin (Barc) (2005) 0.75
[Prognostic influence of immunological subtypes of T-cell acute lymphoblastic leukemia. Study of 81 patients]. Med Clin (Barc) (2006) 0.75
Thermodynamic behavior of the binaries 1-butylpyridinium tetrafluoroborate with water and alkanols: their interpretation using 1H NMR spectroscopy and quantum-chemistry calculations. J Phys Chem B (2011) 0.75
[Hepatic angiomyolipoma in two patients infected with hepatitis C virus]. Gastroenterol Hepatol (2007) 0.75
Interactions of ionic liquids and acetone: thermodynamic properties, quantum-chemical calculations, and NMR analysis. J Phys Chem B (2013) 0.75
[Therapeutic management of juxtapapillary duodenal diverticulum]. Cir Esp (2012) 0.75
Analysis of growth during prepubertal years in long-term survivors after pediatric orthotopic liver transplantation. J Pediatr Endocrinol Metab (2004) 0.75
Low plasma levels of antithrombin III in the early post-operative period following pediatric liver transplantation: should they be replaced? A single-center pilot study. Pediatr Transplant (2014) 0.75
Etiology and mortality of spontaneous bacterial peritonitis in liver transplant recipients: a cohort study. Liver Transpl (2014) 0.75
Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients. Liver Transpl (2011) 0.75
Description of the behavior of dichloroalkanes-containing solutions with three [bXmpy][BF4] isomers, using the experimental information of thermodynamic properties, 1H NMR spectral and the COSMO-RS-methodology. J Phys Chem B (2015) 0.75
Applicability of liver transplantation in Catalonia at the end of the millennium. A prospective study of adult patient selection for liver transplantation. Transpl Int (2003) 0.75